NCT06221826View on ClinicalTrials.gov

MEXIDOL® in the Rehabilitation Treatment of Patients With Acute Cerebral Failure

PHASE4CompletedINTERVENTIONAL

Enrollment

60

Participants

Timeline

Start Date

April 17, 2023

Primary Completion Date

September 12, 2023

Study Completion Date

September 12, 2023

Conditions

Ischemic Stroke, Acute

Interventions

DRUG

Mexidol

Neurocytoprotector

Trial Locations (1)

623702

Brain Institute Clinic, Yekaterinburg

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Pharmasoft

INDUSTRY